Form 8-K - Current report:
SEC Accession No. 0001104659-24-108300
Filing Date
2024-10-15
Accepted
2024-10-15 07:00:22
Documents
18
Period of Report
2024-10-09
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2426103d1_8k.htm   iXBRL 8-K 35595
2 EXHIBIT 10.1 tm2426103d1_ex10-1.htm EX-10.1 30093
3 EXHIBIT 10.2 tm2426103d1_ex10-2.htm EX-10.2 47913
4 EXHIBIT 10.3 tm2426103d1_ex10-3.htm EX-10.3 76217
5 EXHIBIT 99.1 tm2426103d1_ex99-1.htm EX-99.1 17886
9 GRAPHIC tm2426103d1_ex99-1img001.jpg GRAPHIC 1934
  Complete submission text file 0001104659-24-108300.txt   430846

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA gdnsf-20241009.xsd EX-101.SCH 3036
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE gdnsf-20241009_lab.xml EX-101.LAB 34240
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gdnsf-20241009_pre.xml EX-101.PRE 22372
21 EXTRACTED XBRL INSTANCE DOCUMENT tm2426103d1_8k_htm.xml XML 3345
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Vireo Growth Inc. (Filer) CIK: 0001771706 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56225 | Film No.: 241369215
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)